MCID: LNG031
MIFTS: 43

Lung Benign Neoplasm

Categories: Cancer diseases, Respiratory diseases, Genetic diseases

Aliases & Classifications for Lung Benign Neoplasm

MalaCards integrated aliases for Lung Benign Neoplasm:

Name: Lung Benign Neoplasm 12 14
Lung Neoplasms 42 69
Tumor of the Lung 12
Lung Tumor 52

Classifications:



External Ids:

Disease Ontology 12 DOID:3683
MeSH 42 D008175
NCIt 47 C3200
SNOMED-CT 64 126713003
UMLS 69 C0024121

Summaries for Lung Benign Neoplasm

MalaCards based summary : Lung Benign Neoplasm, also known as lung neoplasms, is related to glomus tumor and cystadenoma, and has symptoms including hemoptysis An important gene associated with Lung Benign Neoplasm is KRAS (KRAS Proto-Oncogene, GTPase), and among its related pathways/superpathways are MAPK signaling pathway and PI3K-Akt signaling pathway. The drugs Everolimus and Miconazole have been mentioned in the context of this disorder. Affiliated tissues include lung, prostate and pancreas, and related phenotypes are Decreased viability and behavior/neurological

Related Diseases for Lung Benign Neoplasm

Diseases in the Lung Cancer family:

Lung Benign Neoplasm Lung Carcinoma in Situ
Lung Cancer, Egfr-Related Lung Cancer, Gstm1-Related

Diseases related to Lung Benign Neoplasm via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 251)
id Related Disease Score Top Affiliating Genes
1 glomus tumor 29.8 ENO2 NCAM1 SYP
2 cystadenoma 29.2 ENO2 NCAM1 SYP TP53
3 lung cancer 26.0 CADM1 CHGA EGFR ENO2 FHIT HRAS
4 hilar lung neoplasm 11.8
5 pediatric infratentorial ependymoma 10.8 EGFR TP53
6 2q31.1 microdeletion syndrome 10.8 ENO2 SYP
7 breast myoepithelial neoplasm 10.8 KRAS TP53
8 coloboma of inferior eyelid 10.8 KRAS TP53
9 microphthalmia/anophthalmia/coloboma spectrum 10.7 KRAS TP53
10 tubular adenocarcinoma 10.7 EGFR KRAS NKX2-1
11 supratentorial primitive neuroectodermal tumor 10.7 CHGA ENO2
12 malignant skin fibrous histiocytoma 10.7 HRAS KRAS
13 paranasal sinus cancer 10.7 ENO2 SYP
14 extragonadal nonseminomatous germ cell tumor 10.6 EGFR NKX2-1 TP53
15 malignant ovarian mixed epithelial neoplasm 10.6 CHGA SYP
16 situs inversus totalis with cystic dysplasia of kidneys and pancreas 10.6 ENO2 SYP
17 hip subluxation 10.6 EGFR NKX2-1 TP53
18 intraductal breast myoepitheliosis 10.6 CHGA TP53
19 limb ischemia 10.6 HRAS KRAS
20 bronchus adenoma 10.6 ENO2 SYP
21 common bile duct disease 10.6 EGFR KRAS
22 pleuropulmonary blastoma 10.6
23 retinitis pigmentosa 27 10.6 HRAS NKX2-1
24 sebaceous adenocarcinoma 10.6 EGFR KRAS TP53
25 spinal cord ependymoma 10.6 CHGA SYP
26 signet ring cell intrahepatic cholangiocarcinoma 10.6 CHGA SYP
27 endometriosis of uterus 10.6 EGFR KRAS TP53
28 pemphigus foliaceus 10.6 ENO2 SYP
29 pancreatic serous cystic neoplasm 10.6 EGFR KRAS TP53
30 split hand split foot nystagmus 10.6 HRAS TP53
31 childhood infratentorial neoplasm 10.6 EGFR TP53
32 apocrine adenocarcinoma 10.6 EGFR KRAS TP53
33 enteric pattern testicular yolk sac tumor 10.6 CHGA ENO2
34 neurogenic thoracic outlet syndrome 10.6 CHGA SYP
35 pleural empyema 10.5 NKX2-1 SYP TP53
36 schimmelpenning-feuerstein-mims syndrome, somatic mosaic 10.5 HRAS KRAS
37 malignant hyperthermia susceptibility type 3 10.5 ENO2 HRAS
38 hypogonadotropic hypogonadism-retinitis pigmentosa syndrome 10.5 EGFR SYP TP53
39 bone development disease 10.5 NKX2-1 SYP TP53
40 breast pericanalicular fibroadenoma 10.5 NKX2-1 TP53
41 arteriosclerosis obliterans 10.5 ENO2 NCAM1
42 gorlin bushkell jensen syndrome 10.5 CHGA ENO2
43 skin papilloma 10.5 ENO2 NKX2-1 SYP
44 parachordoma 10.5 KRAS NKX2-1
45 mature teratoma 10.5 ENO2 NKX2-1 SYP
46 aicardi-goutieres syndrome 10.5 CHGA SYP
47 brain glioma 10.5 ENO2 SYP TP53
48 hair disease 10.5 ENO2 SYP TP53
49 rh isoimmunization 10.5 ENO2 SYP TP53
50 ovary rhabdomyosarcoma 10.5 ENO2 HRAS

Graphical network of the top 20 diseases related to Lung Benign Neoplasm:



Diseases related to Lung Benign Neoplasm

Symptoms & Phenotypes for Lung Benign Neoplasm

UMLS symptoms related to Lung Benign Neoplasm:


hemoptysis

GenomeRNAi Phenotypes related to Lung Benign Neoplasm according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Decreased viability GR00055-A-2 9.8 EGFR HRAS KRAS NCAM1
2 Decreased viability GR00106-A-0 9.8 KRAS
3 Decreased viability GR00221-A-1 9.8 EGFR HRAS KRAS
4 Decreased viability GR00221-A-2 9.8 HRAS KRAS
5 Decreased viability GR00221-A-3 9.8 HRAS
6 Decreased viability GR00221-A-4 9.8 EGFR
7 Decreased viability GR00301-A 9.8 KRAS
8 Decreased viability GR00381-A-1 9.8 KRAS
9 Increased cell migration GR00055-A-3 8.92 EGFR HRAS KRAS NCAM1

MGI Mouse Phenotypes related to Lung Benign Neoplasm:

44 (show all 15)
id Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 10.29 CADM1 ENO2 HRAS KRAS NCAM1 NKX2-1
2 growth/size/body region MP:0005378 10.27 HRAS KRAS NKX2-1 RAF1 RARB SCGB1A1
3 mortality/aging MP:0010768 10.23 CHGA EGFR FHIT HRAS KRAS NCAM1
4 endocrine/exocrine gland MP:0005379 10.21 CADM1 CHGA EGFR HRAS KRAS NKX2-1
5 cardiovascular system MP:0005385 10.19 CHGA EGFR HRAS KRAS NKX2-1 RAF1
6 nervous system MP:0003631 10.14 HRAS KRAS NCAM1 NKX2-1 RAF1 RARB
7 immune system MP:0005387 10.13 CADM1 EGFR FHIT KRAS RAF1 RARB
8 neoplasm MP:0002006 10.09 NKX2-1 RAF1 SCGB1A1 SFTPC TP53 EGFR
9 craniofacial MP:0005382 10.07 EGFR ENO2 HRAS KRAS RAF1 RARB
10 normal MP:0002873 10.02 CADM1 EGFR HRAS KRAS NKX2-1 RAF1
11 no phenotypic analysis MP:0003012 9.91 EGFR HRAS KRAS NKX2-1 RAF1 SFTPC
12 renal/urinary system MP:0005367 9.8 HRAS KRAS RARB SCGB1A1 TP53 CHGA
13 reproductive system MP:0005389 9.76 TP53 CADM1 CHGA EGFR KRAS NKX2-1
14 respiratory system MP:0005388 9.65 EGFR ENO2 HRAS KRAS NKX2-1 RAF1
15 vision/eye MP:0005391 9.17 EGFR KRAS NCAM1 RAF1 RARB SFTPC

Drugs & Therapeutics for Lung Benign Neoplasm

Drugs for Lung Benign Neoplasm (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 93)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Everolimus Approved Phase 3 159351-69-6 6442177
2
Miconazole Approved, Investigational, Vet_approved Phase 3 22916-47-8 4189
3
Sirolimus Approved, Investigational Phase 3 53123-88-9 5284616 6436030 46835353
4
Doxorubicin Approved, Investigational Phase 3 23214-92-8 31703
5
Ifosfamide Approved Phase 3 3778-73-2 3690
6
Lenograstim Approved Phase 3 135968-09-1
7
Ethanol Approved Phase 2, Phase 3 64-17-5 702
8
Paclitaxel Approved, Vet_approved Phase 2, Phase 3 33069-62-4 36314
9
Pancrelipase Approved Phase 2, Phase 3 53608-75-6
10
Doxil Approved June 1999 Phase 3 31703
11 Anti-Infective Agents Phase 3,Phase 2
12 Anti-Bacterial Agents Phase 3
13 Antibiotics, Antitubercular Phase 3
14 Antifungal Agents Phase 3
15 Immunosuppressive Agents Phase 3
16 Alkylating Agents Phase 3
17 Isophosphamide mustard Phase 3
18 Topoisomerase Inhibitors Phase 3
19 Albumin-Bound Paclitaxel Phase 2, Phase 3
20 Anti-Infective Agents, Local Phase 2, Phase 3
21 Antimitotic Agents Phase 2, Phase 3
22 Antineoplastic Agents, Phytogenic Phase 2, Phase 3
23 Central Nervous System Depressants Phase 2, Phase 3
24 Gastrointestinal Agents Phase 2, Phase 3
25 pancreatin Phase 2, Phase 3
26 Pharmaceutical Solutions Phase 2, Phase 3
27
Aspirin Approved, Vet_approved Phase 2 50-78-2 2244
28
Glutamic Acid Approved, Nutraceutical Phase 2 56-86-0 33032
29
Glucosamine Approved, Nutraceutical Phase 1, Phase 2 3416-24-8 439213
30 Protective Agents Phase 2
31 Cariostatic Agents Phase 2
32 Deoxyglucose Phase 2
33 Fluorides Phase 2
34 Fluorodeoxyglucose F18 Phase 2
35 Radiopharmaceuticals Phase 2
36 Anticoagulants Phase 1, Phase 2
37 Antimetabolites Phase 1, Phase 2
38 Fibrinolytic Agents Phase 1, Phase 2
39 Glucuronyl glucosamine glycan sulfate Phase 1, Phase 2
40 Hypoglycemic Agents Phase 1, Phase 2
41 Hypolipidemic Agents Phase 1, Phase 2
42 Lipid Regulating Agents Phase 1, Phase 2
43 Analgesics Phase 2
44 Analgesics, Non-Narcotic Phase 2
45 Anti-Inflammatory Agents Phase 2
46 Anti-Inflammatory Agents, Non-Steroidal Phase 2
47 Antipyretics Phase 2
48 Antirheumatic Agents Phase 2
49 Cyclooxygenase Inhibitors Phase 2
50 Peripheral Nervous System Agents Phase 2

Interventional clinical trials:

(show top 50) (show all 65)

id Name Status NCT ID Phase Drugs
1 Comparison of the Ultra-low-dose Veo Algorithm With the Gold Standard Filtered Back Projection for Detecting Pulmonary Asbestos-related Conditions Completed NCT01955018 Phase 4
2 Study to See if Microcoil Insertion Reduces the Rate of Open Thoracotomy for Removal of Lung Nodules Completed NCT01028417 Phase 3
3 Efficacy and Safety of RAD001 in Patients Aged 18 and Over With Angiomyolipoma Associated With Either Tuberous Sclerosis Complex (TSC) or Sporadic Lymphangioleiomyomatosis (LAM) Completed NCT00790400 Phase 3 Everolimus (RAD001);Everolimus Placebo
4 Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma Completed NCT00002764 Phase 3 doxorubicin hydrochloride;ifosfamide
5 Long Term Outcomes After EUS-guided Ablation for Cystic Tumors of the Pancreas Active, not recruiting NCT00689715 Phase 2, Phase 3
6 Bronchoscopic Approach to the Peripheral Lung Nodule - An Alternative Approach Completed NCT00925210 Phase 2
7 18F-FSPG PET/CT in Imaging Patients With Newly Diagnosed Lung Cancer or Indeterminate Pulmonary Nodules Recruiting NCT02448225 Phase 2 Fluorine F 18 L-glutamate Derivative BAY94-9392
8 Incentive Spirometry Added to Physiotherapy to Reduce Postoperative Pulmonary Complications After Lung Surgery Recruiting NCT02146092 Phase 2
9 Airway and/or Pulmonary Vessels Transplantation Recruiting NCT01331863 Phase 1, Phase 2
10 Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules Active, not recruiting NCT02169271 Phase 2 Aspirin
11 NIR Fluorescence Imaging Technique in Thoracic Surgery With ICG Enrolling by invitation NCT02611245 Phase 1 Indocyanine green
12 Optical Coherence Tomography of the Airway for Lung Cancer or Lung Disease Withdrawn NCT00733252 Phase 1
13 Evaluate the Auxiliary Diagnostic Value of Circulating Tumor Cells in Benign and Malignant Lung Nodules Unknown status NCT02653859
14 Tumor Bank for Tissue Samples Unknown status NCT01789229
15 Tumor Bank for Blood Samples Unknown status NCT01763125
16 Clinical Application of 18F-3'-Fluoro-3'-Deoxy-L-thymidine (18F-FLT) Positron Emission Tomography (PET) in Lung Tumors Unknown status NCT01089894
17 The Role of the Vagus Nerve in Tumor-to-Brain Communication in Lung Cancer Patients Unknown status NCT00397124
18 Evaluating the Pulmonary Nodule With Imaging and Biomarkers Unknown status NCT01739881
19 Mechanisms of Immunosurveillance for Lung Cancer Unknown status NCT01710319
20 Endobronchial Ultrasound Guided Transbronchial Lung Biopsy With or Without Guide Sheath in Lung Tumors and the Analysis of Echoic Patterns of Lung Tumors and Mediastinal Lymph Nodes, and the Association Between Diagnostic Yield of Transbronchial Lung Biop Unknown status NCT00415337
21 Differentiation of Malig. & Ben. Solitary Pulm. Nodules & Prediction of Clin. Outcome Using Perfus. Analysis of DCEMRI Unknown status NCT00172575
22 Clinical Trial of Quantitative Detection Kit for Hsp90α in Hepatic Cancer Unknown status NCT02324127
23 Conventional Bronchoscopy Plus Rose Versus Electromagnetic Navigation (EMN) Plus Rose in Small Peripheral Lesions Unknown status NCT00880945
24 Correlation Research of Thioredoxin Reductase in Lung Cancer Completed NCT01985113
25 Assessment of Probe Based Confocal Laser Endo-microscopy for In-vivo Diagnosis of Peripheral Lung Nodules and Masses. Completed NCT01931579
26 Biomarkers for Diagnosis of Lung Cancer Completed NCT02050100
27 Tumor Markers in Lung Cancer: DCAMLK-1LK-1 Completed NCT01578018
28 Paraoxanase Enzyme Activity in Patients With Pulmonary Diseases Completed NCT02800382
29 Non-Invasive Biomarkers For Early Detection Of Lung Cancers Completed NCT01580332
30 The Effect of Direct Referral for Fast CT Scan in Early Lung Cancer Detection in General Practice Completed NCT01527214
31 A Pilot Study of PET-CT in the Assessment of Pulmonary Nodules in Children With Malignant Solid Tumors Completed NCT00629460
32 Optical Detection of Malignancy During Percutaneous Interventions Completed NCT01730365
33 False/Negative Rate of Lung Percutaneous Needle Biopsy Completed NCT00638352
34 Thoracoscopic Localization of Pulmonary Nodules Using Direct Intracavitary Thoracoscopic Ultrasound Completed NCT01201824
35 Serum Biomarkers in Diagnosis of Mesothelioma Completed NCT02029105
36 Predictive Value of Prostate-specific Antigen Isoform p2psa and Its Derivates in the Diagnosis of Prostate Cancer Completed NCT01672411
37 Characterization of Patients With Tuberous Sclerosis Complex, Lymphangioleiomyomatosis and Angiomyolipoma Recruiting NCT02325505
38 The Value of VOCs Analysis in Exhaled Breath for Pulmonary Benign and Malignant Lesion Diagnosis Recruiting NCT02965300
39 Genetic Analysis of Birt Hogg-Dube Syndrome and Characterization of Predisposition to Kidney Cancer Recruiting NCT00033137
40 Perfusion CT Imaging in Lung Cancer With SBRT Recruiting NCT02755454
41 Natural History Study of Patients With Neurofibromatosis Type I Recruiting NCT00924196
42 Early Diagnosis of Small Pulmonary Nodules by Multi-omics Sequencing Recruiting NCT03320044
43 DECAMP-1: Diagnosis and Surveillance of Indeterminate Pulmonary Nodules Recruiting NCT01785342
44 A Case-Control Study to Verify Diagnostic Performance of AminoIndex™ Technology Recruiting NCT02512757
45 Early Diagnosis of Lung Cancer and Mesothelioma in Prior Asbestos Workers Recruiting NCT00188890
46 Piloting the Feasibility of FLT-PET/CT Non-Small Cell Lung Cancer Managed With SBRT Recruiting NCT02456246
47 Quantification of microRNAs in Diagnosis of Pulmonary Nodules Recruiting NCT03293433
48 Study on Fluids Associated to Lung Cancer Recruiting NCT02853006
49 Prospective Study on the Treatment of Unsuspected Pulmonary Embolism in Cancer Patients Recruiting NCT01727427 Heparin, fondaparinux, vitamin-K antagonists, aspirin
50 Venous Thromboembolic Complications in Ovarian Cancer Recruiting NCT02480790

Search NIH Clinical Center for Lung Benign Neoplasm

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: lung neoplasms

Genetic Tests for Lung Benign Neoplasm

Anatomical Context for Lung Benign Neoplasm

MalaCards organs/tissues related to Lung Benign Neoplasm:

39
Lung, Prostate, Pancreas, Testes, Liver, Brain, Kidney

Publications for Lung Benign Neoplasm

Variations for Lung Benign Neoplasm

Expression for Lung Benign Neoplasm

Search GEO for disease gene expression data for Lung Benign Neoplasm.

Pathways for Lung Benign Neoplasm

Pathways related to Lung Benign Neoplasm according to GeneCards Suite gene sharing:

(show top 50) (show all 61)
id Super pathways Score Top Affiliating Genes
1 12.68 EGFR HRAS KRAS RAF1 TP53
2 12.64 EGFR HRAS KRAS RAF1 TP53
3
Show member pathways
12.63 EGFR HRAS KRAS RAF1 TP53
4
Show member pathways
12.55 EGFR HRAS KRAS TP53
5 12.53 ENO2 NCAM1 NKX2-1 SYP
6 12.51 EGFR HRAS KRAS RAF1 RARB TP53
7 12.47 EGFR HRAS KRAS RAF1 TP53
8
Show member pathways
12.45 EGFR FHIT HRAS KRAS RAF1 RARB
9
Show member pathways
12.44 EGFR HRAS KRAS RAF1 TP53
10
Show member pathways
12.42 EGFR HRAS KRAS TP53
11
Show member pathways
12.41 EGFR HRAS KRAS RAF1 TP53
12
Show member pathways
12.38 EGFR HRAS KRAS RAF1
13
Show member pathways
12.37 EGFR HRAS KRAS RAF1
14
Show member pathways
12.34 HRAS KRAS RAF1 TP53
15
Show member pathways
12.34 EGFR HRAS KRAS RAF1
16
Show member pathways
12.21 EGFR HRAS KRAS RAF1
17
Show member pathways
12.2 EGFR HRAS KRAS RAF1 TP53
18
Show member pathways
12.19 EGFR HRAS KRAS RAF1 TP53
19
Show member pathways
12.18 HRAS KRAS RAF1 TP53
20 12.17 EGFR HRAS KRAS RAF1
21 12.16 EGFR HRAS KRAS RAF1 TP53
22
Show member pathways
12.15 HRAS KRAS RAF1 TP53
23
Show member pathways
12.12 HRAS KRAS RAF1 TP53
24
Show member pathways
12.11 EGFR HRAS KRAS RAF1
25
Show member pathways
12.05 EGFR HRAS KRAS RAF1
26
Show member pathways
12.01 EGFR HRAS KRAS TP53
27
Show member pathways
12 EGFR RAF1 TP53
28
Show member pathways
11.99 HRAS KRAS RAF1
29 11.99 HRAS KRAS RAF1
30 11.96 HRAS KRAS RAF1 TP53
31 11.95 HRAS KRAS TP53
32 11.94 HRAS KRAS RAF1
33 11.93 HRAS KRAS RAF1 TP53
34 11.92 HRAS KRAS RAF1
35
Show member pathways
11.92 EGFR HRAS KRAS
36 11.91 HRAS RAF1 TP53
37 11.86 EGFR HRAS KRAS RAF1
38 11.84 EGFR HRAS KRAS RAF1 TP53
39 11.8 FHIT RARB TP53
40 11.8 KRAS RAF1 TP53
41
Show member pathways
11.79 HRAS KRAS RAF1
42 11.7 EGFR HRAS KRAS RAF1 TP53
43 11.69 EGFR HRAS KRAS RAF1
44 11.67 HRAS RAF1 TP53
45 11.66 HRAS KRAS TP53
46
Show member pathways
11.66 HRAS KRAS RAF1
47 11.62 HRAS KRAS RAF1
48
Show member pathways
11.59 EGFR HRAS RAF1
49 11.59 EGFR HRAS KRAS
50 11.47 HRAS RAF1 TP53

GO Terms for Lung Benign Neoplasm

Biological processes related to Lung Benign Neoplasm according to GeneCards Suite gene sharing:

(show all 14)
id Name GO ID Score Top Affiliating Genes
1 positive regulation of transcription from RNA polymerase II promoter GO:0045944 9.97 EGFR HRAS NKX2-1 RAF1 RARB TP53
2 apoptotic process GO:0006915 9.92 CADM1 FHIT HRAS RAF1 TP53
3 stimulatory C-type lectin receptor signaling pathway GO:0002223 9.71 HRAS KRAS RAF1
4 axon guidance GO:0007411 9.62 HRAS KRAS NCAM1 NKX2-1
5 Ras protein signal transduction GO:0007265 9.61 HRAS KRAS TP53
6 positive regulation of MAP kinase activity GO:0043406 9.58 EGFR HRAS KRAS
7 positive regulation of protein phosphorylation GO:0001934 9.56 EGFR HRAS KRAS RAF1
8 epidermal growth factor receptor signaling pathway GO:0007173 9.54 EGFR HRAS KRAS
9 epithelial tube branching involved in lung morphogenesis GO:0060441 9.51 KRAS NKX2-1
10 cerebral cortex cell migration GO:0021795 9.48 EGFR NKX2-1
11 response to isolation stress GO:0035900 9.46 HRAS KRAS
12 MAPK cascade GO:0000165 9.35 EGFR HRAS KRAS NCAM1 RAF1
13 ERBB2 signaling pathway GO:0038128 9.33 EGFR HRAS KRAS
14 regulation of long-term neuronal synaptic plasticity GO:0048169 8.8 HRAS KRAS SYP

Molecular functions related to Lung Benign Neoplasm according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 identical protein binding GO:0042802 9.43 EGFR FHIT RAF1 SFTPC SYP TP53
2 nucleotide binding GO:0000166 9.02 EGFR FHIT HRAS KRAS RAF1

Sources for Lung Benign Neoplasm

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....